...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Have a great Sunday, especially those of you like me that are celebrating Orthodox Easter ... As well as those of you who are also like me and mourning another Maple Leafs Game 7 exit ... Ugggh!

Sincerely,

George et al

Message: Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement

Toinv - agree with all of your points plus possibly Zenith Epigenetics Ltd (maybe). It could be a very interesting finish to the year for our companies. The CKD angle could carry an enormous amount of weight in any deal decision at this time as there is a limited amount of competition in that area.

Your last point of RVX finally achieving some scientific credibility is well stated. There seems to be a lot more positives this time around than at any other time in the past that I can remember.

The sweatest thing we could hear prior to a deal being announced is the DSMB say "continue on the way you are with no changes". In my mind a comment like that would essentially say the drug is doing everything it is supposed to be doing, safely, without actually saying those exact words.

dyodd

tada

Share
New Message
Please login to post a reply